Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.

Badje A, Moh R, Gabillard D, Guéhi C, Kabran M, Ntakpé JB, Carrou JL, Kouame GM, Ouattara E, Messou E, Anzian A, Minga A, Gnokoro J, Gouesse P, Emieme A, Toni TD, Rabe C, Sidibé B, Nzunetu G, Dohoun L, Yao A, Kamagate S, Amon S, Kouame AB, Koua A, Kouamé E, Daligou M, Hawerlander D, Ackoundzé S, Koule S, Séri J, Ani A, Dembélé F, Koné F, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatunde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Karcher S, Rouzioux C, Kouame A, Assi R, Bakayoko A, Domoua SK, Deschamps N, Aka K, N'Dri-Yoman T, Salamon R, Journot V, Ahibo H, Ouassa T, Menan H, Inwoley A, Danel C, Eholié SP, Anglaret X; Temprano ANRS 12136 Study Group.

Lancet Glob Health. 2017 Nov;5(11):e1080-e1089. doi: 10.1016/S2214-109X(17)30372-8.

2.

Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies.

Jaquet A, Nouaman M, Tine J, Tanon A, Anoma C, Inwoley A, Attia A, Ekouevi DK, Seydi M, Dabis F, Wandeler G.

Liver Int. 2017 Aug;37(8):1116-1121. doi: 10.1111/liv.13484. Epub 2017 Jun 22.

3.

Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast.

Bouscaillou J, Evanno J, Prouté M, Inwoley A, Kabran M, N'Guessan T, Djé-Bi S, Sidibé S, Thiam-Niangoin M, N'guessan BR, Blanchetière P, Luhmann N.

Int J Drug Policy. 2016 Apr;30:116-23. doi: 10.1016/j.drugpo.2016.02.010. Epub 2016 Feb 17.

PMID:
26964902
4.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.

5.

Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.

Danel C, Kabran M, Inwoley A, Badje A, Herrmann JL, Moh R, Lecarrou J, Gabillard D, Ntakpe JB, Deschamps N, Ouattara E, Perronne C, Eholie S, Anglaret X.

PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245. eCollection 2014.

6.

Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration.

Tchounga BK, Inwoley A, Coffie PA, Minta D, Messou E, Bado G, Minga A, Hawerlander D, Kane C, Eholie SP, Dabis F, Ekouevi DK; WADA Collaboration.

J Int AIDS Soc. 2014 Aug 11;17:19064. doi: 10.7448/IAS.17.1.19064. eCollection 2014.

7.

Interest in Determining the CD34+ CD38- Phenotype in the Diagnosis and Prognosis of Acute Leukemia in Abidjan - Côte d'Ivoire.

Sawadogo D, Tolo A, Kassi H, Sangare M, Inwoley A.

Mediterr J Hematol Infect Dis. 2013 Apr 10;5(1):e2013023. doi: 10.4084/MJHID.2013.023. Print 2013.

8.

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters.

Minga AK, Lewden C, Gabillard D, Bomisso GI, Toni TD, Emième AA, Yapo V, Inwoley A, Salamon R, Anglaret X; Agence Nationale de Recherches sur le Sida (ANRS) 1220 Primo-CI Study Group.

AIDS. 2011 Mar 27;25(6):819-23. doi: 10.1097/QAD.0b013e32834625d3.

9.

Comparison of early CD4 T-cell count in HIV-1 seroconverters in Côte d'Ivoire and France: the ANRS PRIMO-CI and SEROCO cohorts.

Lewden C, Thiébaut R, Boufassa F, Coulibaly A, Malateste K, Seng R, Toni TD, Inwoley A, Rouzioux C, Minga A, Anglaret X, Meyer L.

J Acquir Immune Defic Syndr. 2010 Feb;53(2):260-5. doi: 10.1097/QAI.0b013e3181b84260.

PMID:
19745754
10.

Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adults.

Danel C, Gabillard D, Inwoley A, Chaix ML, Toni TD, Moh R, Messou E, Bissagnene E, Salamon R, Eholie S, Anglaret X.

AIDS Res Hum Retroviruses. 2009 Aug;25(8):783-93. doi: 10.1089/aid.2009.0018.

PMID:
19619008
11.

Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children.

Rouet F, Chaix ML, Kpozehouen A, Inwoley A, Anaky MF, Fassinou P, Rouzioux C, Blanche S, Msellati P.

J Trop Pediatr. 2009 Dec;55(6):409-12. doi: 10.1093/tropej/fmp034. Epub 2009 May 15.

PMID:
19447821
12.

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC.

J Virol. 2009 Jul;83(14):7337-48. doi: 10.1128/JVI.00110-09. Epub 2009 May 13.

13.

Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults.

Messou E, Gabillard D, Moh R, Inwoley A, Sorho S, Eholié S, Rouet F, Seyler C, Danel C, Anglaret X.

Bull World Health Organ. 2008 Jun;86(6):435-42.

14.

CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in Abidjan.

Duvignac J, Anglaret X, Kpozehouen A, Inwoley A, Seyler C, Toure S, Gourvellec G, Messou E, Gabillard D, Thiébaut R.

HIV Clin Trials. 2008 Jan-Feb;9(1):26-35. doi: 10.1310/hct0901-26.

PMID:
18215979
15.

Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.

Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1338-47. doi: 10.1089/aid.2006.0308.

16.

Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.

Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassinou P, Kpozehouen A, Rouzioux C, Blanche S, Msellati P; Programme Enfant Yopougon (Agence Nationale de Recherches sur le SIDA et les Hépatites Virales B et C 1244/1278).

Clin Infect Dis. 2008 Feb 1;46(3):361-6. doi: 10.1086/525531.

PMID:
18171303
17.

Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings.

Ekouevi DK, Inwoley A, Tonwe-Gold B, Danel C, Becquet R, Viho I, Rouet F, Dabis F, Anglaret X, Leroy V.

AIDS Res Hum Retroviruses. 2007 Dec;23(12):1469-74.

18.

Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.

Rouet F, Fassinou P, Inwoley A, Anaky MF, Kouakoussui A, Rouzioux C, Blanche S, Msellati P; ANRS 1244/1278 Programme Enfants Yopougon.

AIDS. 2006 Nov 28;20(18):2315-9.

PMID:
17117017
19.

CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings.

Rouet F, Inwoley A, Ekouevi DK, Viho I, Becquet R, Sakarovitch C, Bequet L, Tonwe-Gold B, Chaix ML, Leroy V, Rouzioux C, Dabis F; ANRS 1201/1202 Ditrame Plus Study Group.

J Trop Pediatr. 2006 Oct;52(5):346-54. Epub 2006 Jun 16.

PMID:
16782723
20.

Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Côte d'Ivoire.

Toure S, Gabillard D, Inwoley A, Seyler C, Gourvellec G, Anglaret X.

Trans R Soc Trop Med Hyg. 2006 Aug;100(8):785-90. Epub 2006 Feb 3.

PMID:
16458337
21.

Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.

Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A, Gomis OB, Konga C, Inwoley A, Gabillard D, Bissagnene E, Salamon R, Anglaret X.

Antivir Ther. 2005;10(5):615-24.

PMID:
16152755
22.

Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa).

Inwoley A, Recordon-Pinson P, Dupuis M, Gaston J, Genête M, Minga A, Letourneur F, Rouet F, Choppin J, Fleury H, Guillet JG, Andrieu M; ANRS 1220 PRIMO-CI Study Group.

AIDS Res Hum Retroviruses. 2005 Jul;21(7):620-8.

PMID:
16060833
23.

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, Danel C, Anglaret X, Leroy V, Msellati P, Dabis F, Rouzioux C.

J Clin Microbiol. 2005 Jun;43(6):2709-17.

24.
25.

HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.

Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C; ANRS 1236 DITRAME-B&C Study Group.

J Med Virol. 2004 Sep;74(1):34-40.

PMID:
15258966
26.

Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa.

Ekouevi DK, Rouet F, Becquet R, Inwoley A, Viho I, Tonwe-Gold B, Bequet L, Dabis F, Leroy V; ANRS 1201/1202 Ditrame Plus Study Group.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):755-7.

27.

Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.

Seyler C, Anglaret X, Dakoury-Dogbo N, Messou E, Touré S, Danel C, Diakité N, Daudié A, Inwoley A, Maurice C, Tonwe-Gold B, Rouet F, N'Dri-Yoman T, Salamon R; ANRS 1203 Study Group.

Antivir Ther. 2003 Oct;8(5):385-93.

PMID:
14640385
28.

Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study.

Diagbouga S, Chazallon C, Kazatchkine MD, Van de Perre P, Inwoley A, M'Boup S, David MP, Ténin AT, Soudré R, Aboulker JP, Weiss L.

AIDS. 2003 Oct 17;17(15):2201-8.

PMID:
14523277

Supplemental Content

Loading ...
Support Center